Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Home > Directory > Life Sciences > Carigent Therapeutics Inc.

Carigent Therapeutics Inc.

Carigent is a privately held biotechnology firm located in New Haven, CT dedicated to the development of next generation therapeutics and diagnostic agents using a propriety drug delivery platform which is extremely versatile and robust. The platform allows for controlled release of therapeutic agents, tethering of surface ligands, targeting of therapy to a particular physiological site, and the ability to combine multiple agents into one vehicle made primarily from FDA approved materials. The technology is unique since it incorporates a high density of surface ligands into established, well-characterized, safe materials which allow…

§ incredible flexibility in targeting the delivery system for a variety of disease states

§ ability to combine imaging agents with drug, and/or

§ enhancment of in vivo circulation times.

The company was founded in 2007 with a team focused on generating a comprehensive product pipeline in multiple therapeutic areas including cancer treatment, antibody therapeutics, and siRNA delivery. The business strategy centers on the core technology of surface-modified, nanoparticle encapsulation of therapeutic agents where Carigent develops drug products both internally and in collaboration with pharmaceutical and biotechnology industry leaders, using generic, commercially available drugs or proprietary compounds.


5 Science Park, Suite 13
New Haven, CT 06520 USA
203 752 0808

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project